Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Savine Therapeutics

2007 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of therapeutics software designed to develop scrambled antigen vaccine (Savine). The company's therapeutics software is used to design antigens which are scrambled or re-engineered from key proteins, enabling doctors and physicians to retain immunologically-relevant characteristics while removing dangerous functions through a vaccine.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Technology Systems
Acquirer
Primary Office
  • 15 London Circuit
  • Suite 1, Level 8
  • Canberra, Australian Capital Territory 2600
  • Australia

Savine Therapeutics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Savine Therapeutics‘s full profile, request access.

Request full access to PitchBook

Savine Therapeutics Executive Team (2)

Name Title Board
Seat
Contact
Info
Ian Ramshaw Co-Founder
Scott Thomspon Co-Founder